FIFTH INTERNATIONAL SYMPOSIUM ON EBV AND ASSOCIATED DIS
第五届 EBV 及相关 DIS 国际研讨会
基本信息
- 批准号:3434277
- 负责人:
- 金额:$ 0.85万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1992
- 资助国家:美国
- 起止时间:1992-08-11 至 1993-08-10
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Based on the importance of the Epstein-Barr Virus as an established
disease-causing agent world-wide, the new diseases now being associated
with this virus, the growing number of investigators in the field, the
international features of EBV-associated diseases, and the impact of EBV
infection in AIDS, we plan to hold the fifth International Symposium on
Epstein-Barr Virus and Associated Malignant Diseases in Annecy, France,
September 13-19, 1992. These biennial symposia, sponsored by the
International Association for Research On Epstein-Barr Virus and Associated
Diseases, provide the only regular forum for EBV research. The aims are:
1. Define more precisely EBV-associated diseases, old and newly emerging,
in pathobiologic and molecular terms from basic and clinical perspectives.
2. Provide an interdisciplinary forum to consider the explosion of
information on regulation of EBV gene expression both at the
transcriptional and protein levels, replication, and recombination.
3. Consider newly emerging mechanisms of oncogenesis triggered by EBV
infection including interactions with oncogenes and growth-suppressor
genes.
4. Consider the new evidence for an association of EBV and Hodgkin's
Disease as well as the EBV-triggered lymphomas in AIDS and in post-
transplant recipients.
5. Examine the latest pathogenetic and molecular features together with
the epidemiology of the most important EBV-associated disease,
nasopharyngeal carcinoma (NPC).
6. Invite new approaches to treatment, early diagnosis and prevention of
EBV infection and diseases.
7. Recognize and encourage new young investigators and new developments in
the field and identify areas for future investigation.
8. Stimulate active communication and interactions internationally among
clinical and basic scientists in order to facilitate exchange of
information and materials and rapid movement of new basic information to
clinical settings.
Four hundred participants including basic scientists, epidemiologists,
geneticists and clinicians from North America, Europe, Asia and Africa are
expected. This is an open meeting that will accept after screening
unsolicited abstracts as well as the invited overview talks and solicited
submissions. Essentially every established EBV investigator and a large
number of younger investigators are included on the program which has been
designed to take note of new developments and to retain its
interdisciplinary character. This application requests partial support for
two-thirds of the invited EBV experts from the USA.
基于爱泼斯坦-巴尔病毒作为一种既定的
全球范围内的致病因素,新的疾病,
有了这种病毒,越来越多的调查人员在外地,
EB病毒相关疾病的国际特征,以及EB病毒的影响
我们计划举办第五届国际研讨会,
爱泼斯坦-巴尔病毒和相关恶性疾病在法国阿讷西,
1992年9月13日至19日。 这些两年一次的研讨会由
国际爱泼斯坦-巴尔病毒及相关病毒研究协会
疾病,为EBV研究提供唯一的定期论坛。 其目标是:
1. 更精确地定义EBV相关疾病,旧的和新出现的,
在病理生物学和分子方面从基础和临床的角度。
2. 提供一个跨学科的论坛,以考虑
关于EBV基因表达调控的信息,
转录和蛋白质水平、复制和重组。
3. 考虑EBV引发的新出现的肿瘤发生机制
感染,包括与癌基因和生长抑制基因的相互作用
基因.
4. 考虑到EB病毒和霍奇金淋巴瘤相关的新证据,
疾病以及艾滋病和艾滋病后EB病毒引发的淋巴瘤
移植接受者
5. 研究最新的致病和分子特征,
最重要的EB病毒相关疾病的流行病学,
鼻咽癌(NPC)。
6. 邀请新的治疗、早期诊断和预防方法,
EB病毒感染与疾病
7. 认可和鼓励新的年轻研究人员和新的发展,
并确定未来调查的领域。
8. 促进国际间的积极沟通和互动,
临床和基础科学家,以促进交流
新的基本信息的迅速流动,
临床环境。
四百名参与者包括基础科学家,流行病学家,
来自北美、欧洲、亚洲和非洲的遗传学家和临床医生,
预期 这是一个公开的会议,将接受筛选后
未经请求的摘要以及邀请的概述会谈和征求
意见书。 基本上每一个既定的EBV研究者和一个大的
一些年轻的研究人员被列入该计划,
旨在注意到新的事态发展,
跨学科特征。 此应用程序请求部分支持
三分之二的受邀EBV专家来自美国。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JOSEPH S PAGANO其他文献
JOSEPH S PAGANO的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JOSEPH S PAGANO', 18)}}的其他基金
PREVENTION AND ANTIVIRAL TREATMENT FOR EBV LYMPHOMAGENESIS
EBV 淋巴生成的预防和抗病毒治疗
- 批准号:
8502416 - 财政年份:2012
- 资助金额:
$ 0.85万 - 项目类别:
PREVENTION AND ANTIVIRAL TREATMENT FOR EBV LYMPHOMAGENESIS
EBV 淋巴生成的预防和抗病毒治疗
- 批准号:
8410979 - 财政年份:2012
- 资助金额:
$ 0.85万 - 项目类别:
CELLULAR AND VIRAL REGULATION OF TYPE III EBV LATENCY
III 型 EBV 潜伏期的细胞和病毒调控
- 批准号:
6930188 - 财政年份:2005
- 资助金额:
$ 0.85万 - 项目类别:
CELLULAR REGULATION OF TYPE III EBV LATENCY
III 型 EBV 潜伏期的细胞调节
- 批准号:
6642890 - 财政年份:2002
- 资助金额:
$ 0.85万 - 项目类别:
CELLULAR REGULATION OF TYPE III EBV LATENCY
III 型 EBV 潜伏期的细胞调节
- 批准号:
6493592 - 财政年份:2001
- 资助金额:
$ 0.85万 - 项目类别: